Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation

Related

  1. Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
    Hao Wang, Yifei Zhang, Zhen Li +5
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  2. A Pathological Image-Based Pathomics Signature Combined with Clinicopathological Features for Predicting Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma: A Development and External Validation Study
    Kaiming Peng, Jieming Lu, Peipei Zhang +5
    CancersPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  3. FMOD marks a low-malignancy epithelial state in prostate cancer: an ECM-related prognostic signature with single-cell and functional validation.
    Zhen Li, Xinyang Cai, Yichi Zhang +4
    Cell adhesion & migrationPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Development and validation of an interpretable clinical-radiomics model for predicting 3-year postoperative recurrence in clinical stage I lung adenocarcinoma: a multicentre study.
    Qiushi Su, Bingyan Wang, Pei Nie +1
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  5. Development and validation of a prognostic prediction model for elderly patients with sepsis-associated acute kidney injury based on interpretable machine learning
    Nan Zhang, Jian-Zhong Wang, Qi Ma +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
BibTeX
@article{nan2026interpretable,
  title = {{An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation}},
  author = {Haocheng Nan and Rong Di and Xiaorong Kou and Gang Ma},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-73601-9},
  url = {https://www.nature.com/articles/s41598-026-73601-9},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation
AU  - Haocheng Nan
AU  - Rong Di
AU  - Xiaorong Kou
AU  - Gang Ma
PY  - 2026
DA  - 2026/10/12
JO  - Scientific Reports
DO  - 10.1038/s41598-026-73601-9
UR  - https://www.nature.com/articles/s41598-026-73601-9
SN  - 2045-2322
ER  -